Skip to main content

Table 2 Sensitivity of different influenza strains to inhibition by SP-D and their HA glycan attachments

From: Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D

H3N2

SPD

63

81

122

126

133

144

165

246

276

X31 (Aichi/68xA/PR8)

>2 μg

 

+

    

+

  

A/Udorn/72

>2 μg

 

+

    

+

  

A/Shandong/9/93

>2 μg

+

  

+

  

+

+

+

A/Wuhan/359/95

>2 μg

+

  

+

  

+

+

 

A/Sydney/5/97

62 ng

+

 

+

+

+

 

+

+

 

A/Panama/2007/99

7.8 ng

+

 

+

+

+

+

+

+

 

A/Fujian/411/02 (rg)

3.9 ng

+

 

+

+

+

+

+

+

 

Sialic acid distance (Ã…)

 

23

28

20

18

7.6

9.8

20

19

43

H1N1

SPD

71

104

142

144

172

177

   

A/Puerto Rico/8/34

>2 μg

         

A/Memphis/10/78

3.9 ng

 

+

 

+

+

+

   

A/Memphis/7/80

7.8 ng

 

+

 

+

+

+

   

A/Memphis/14/96

1 μg

+

+

+

  

+

   

A/New Caledonia/20/99

>2 μg

+

+

+

  

+

   

A/Memphis/6/2001

1 μg

+

+

+

  

+

   

Sialic acid distance (Ã…)

 

21

17

15

9

13

24

   

H1N1

SPD

170

181

       

A/HK/213/03

2 μg

 

+

       

A/Vietnam/1203/04

>2 μg

+

+

       

Sialic acid distance (Ã…)

 

15

27

       
  1. Notes:
  2. 1. SPD masses refer to amount required in hemagglutination inhibition assay to inhibit influenza-mediated agglutination of chicken and turkey red blood cells.
  3. 2. Numbers refer to amino acid number in the influenza HA "head"; "+" indicates potential N-linked glycosylation site based on sequence. Bold numbers indicate residues with large apparent influence on interaction of virus with SP-D